These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20931507)

  • 1. Adverse event monitoring of artemesinin combination therapy in Nigeria: the challenges and limitations of the study.
    Oshikoya KA
    West Afr J Med; 2010; 29(4):221-4. PubMed ID: 20931507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacovigilance of antimalarial treatment in Africa: is it possible?
    Talisuna AO; Staedke SG; D'Alessandro U
    Malar J; 2006 Jun; 5():50. PubMed ID: 16780575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa.
    Simooya O
    Drug Saf; 2005; 28(4):277-86. PubMed ID: 15783238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda.
    Staedke SG; Jagannathan P; Yeka A; Bukirwa H; Banek K; Maiteki-Sebuguzi C; Clark TD; Nzarubara B; Njama-Meya D; Mpimbaza A; Rosenthal PJ; Kamya MR; Wabwire-Mangen F; Dorsey G; Talisuna AO
    Malar J; 2008 Jun; 7():107. PubMed ID: 18547416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
    Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS
    Malar J; 2011 Mar; 10():57. PubMed ID: 21388536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study.
    Poirot E; Soble A; Ntshalintshali N; Mwandemele A; Mkhonta N; Malambe C; Vilakati S; Pan S; Darteh S; Maphalala G; Brown J; Hwang J; Pace C; Stergachis A; Vittinghoff E; Kunene S; Gosling R
    Malar J; 2016 Jul; 15(1):384. PubMed ID: 27450652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
    Kajungu DK; Erhart A; Talisuna AO; Bassat Q; Karema C; Nabasumba C; Nambozi M; Tinto H; Kremsner P; Meremikwu M; D'Alessandro U; Speybroeck N
    PLoS One; 2014; 9(5):e96388. PubMed ID: 24787710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals.
    Stergachis A; Bartlein RJ; Dodoo A; Nwokike J; Kachur SP
    Malar J; 2010 May; 9():148. PubMed ID: 20509971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.
    Mehta U; Durrheim D; Mabuza A; Blumberg L; Allen E; Barnes KI
    Drug Saf; 2007; 30(10):899-910. PubMed ID: 17867727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward elimination of malaria in Nigeria: uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City.
    Akoria OA; Arhuidese IJ
    Ann Afr Med; 2014; 13(3):104-13. PubMed ID: 24923369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing adverse event forms for real-world reporting: participatory research in Uganda.
    Davies EC; Chandler CI; Innocent SH; Kalumuna C; Terlouw DJ; Lalloo DG; Staedke SG; Haaland A
    PLoS One; 2012; 7(3):e32704. PubMed ID: 22479335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort event monitoring of patients treated for uncomplicated malaria with artemisinin-based combination therapies in selected hospitals and community pharmacies in Nigeria.
    Bassi PU; Osakwe AI; Suku C; Kalat M; Elagbaje C; Isah A; Ayinbuomwan S; Wammanda RD; Bob-Okon II; Ambe J; Mava Y; Adesina AO; Ugochukwu CG; Nyong EE; Ogunleye OO; Onuoha F; Jalo I; Adegoke VO; Balogun ST; Ntadom G; Ejiekpe FN; Tahir R; Dabit K; Amodu AA; Nwaosu S; Habib AT
    Niger Postgrad Med J; 2016; 23(4):172-181. PubMed ID: 28000637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial.
    Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA
    Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets.
    Ding XC; Beck HP; Raso G
    Trends Parasitol; 2011 Feb; 27(2):73-81. PubMed ID: 21169061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana.
    Chatio S; Aborigo R; Adongo PB; Anyorigiya T; Dalinjong PA; Akweongo P; Oduro A
    Malar J; 2016 Feb; 15():125. PubMed ID: 26921239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences and Lessons From Implementing Cohort Event Monitoring Programmes for Antimalarials in Four African Countries: Results of a Questionnaire-Based Survey.
    Suku CK; Hill G; Sabblah G; Darko M; Muthuri G; Abwao E; Pandit J; Osakwe AI; Elagbaje C; Nyambayo P; Khoza S; Dodoo AN; Pal SN
    Drug Saf; 2015 Nov; 38(11):1115-26. PubMed ID: 26267842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of artemisinin combination therapy for the treatment of uncomplicated falciparum malaria in Nigerian children.
    Ojurongbe O; Lawal OA; Abiodun OO; Okeniyi JA; Oyeniyi AJ; Oyelami OA
    J Infect Dev Ctries; 2013 Dec; 7(12):975-82. PubMed ID: 24334945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Pharmacology of Antimalarial Drugs--First AHRO International Malaria Symposium.
    Kurtzhals J
    IDrugs; 2008 Oct; 11(10):713-5. PubMed ID: 18828068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.